Cargando…

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential

Parkinson’s disease (PD), the second most common neurodegenerative disorder after Alzheimer’s disease, is a clinically heterogeneous disorder, with obscure etiology and no disease-modifying therapy to date. Currently, there is no available biomarker for PD endophenotypes or disease progression. Accu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelopoulou, Efthalia, Paudel, Yam Nath, Villa, Chiara, Piperi, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601048/ https://www.ncbi.nlm.nih.gov/pubmed/33036336 http://dx.doi.org/10.3390/brainsci10100713

Ejemplares similares

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
por: Angelopoulou, Efthalia, et al.
Publicado: (2019)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
por: Mishra, Awanish, et al.
Publicado: (2021)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders
por: Villa, Chiara, et al.
Publicado: (2022)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Psychosis in Parkinson’s Disease: A Lesson from Genetics
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Changes in plasma arylsulfatase A level as a compensatory biomarker of early Parkinson’s disease
por: Yoo, Han Soo, et al.
Publicado: (2020)

Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements
por: Bandopadhyay, Ritam, et al.
Publicado: (2021)

Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease
por: Li, Mingjian, et al.
Publicado: (2022)

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Hypoxia Reduces Arylsulfatase B Activity and Silencing Arylsulfatase B Replicates and Mediates the Effects of Hypoxia
por: Bhattacharyya, Sumit, et al.
Publicado: (2012)

Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase): Potential Role as a Biomarker in Prostate Cancer
por: Feferman, Leo, et al.
Publicado: (2013)

Migraine, Tension-Type Headache and Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
por: Degirmenci, Yildiz, et al.
Publicado: (2023)

Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice
por: Blomqvist, Maria, et al.
Publicado: (2011)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Purification and biosynthesis of a derepressible periplasmic arylsulfatase from Chlamydomonas reinhardtii
Publicado: (1988)

Protein structure prediction for novel mutations in Arylsulfatase-A gene
por: Divya, M, et al.
Publicado: (2014)

Anti-diabetic activity of different oils through their effect on arylsulfatases
por: Samarji, Rima, et al.
Publicado: (2014)

Decline in arylsulfatase B leads to increased invasiveness of melanoma cells
por: Bhattacharyya, Sumit, et al.
Publicado: (2016)

Arylsulfatase A pseudodeficiency in Mexico: Enzymatic activity and haplotype analysis
por: Juárez‐Osuna, Jesús A., et al.
Publicado: (2020)

A Possible Role for Arylsulfatase G in Dermatan Sulfate Metabolism
por: Poterala-Hejmo, Aleksandra, et al.
Publicado: (2020)

Novel subtype of mucopolysaccharidosis caused by arylsulfatase K (ARSK) deficiency
por: Verheyen, Sarah, et al.
Publicado: (2022)

Ambiental Factors in Parkinson’s Disease Progression: A Systematic Review
por: Bougea, Anastasia, et al.
Publicado: (2023)

Asa Hill
Publicado: (1875)

Upregulation of arylsulfatase B in carotid atherosclerosis is associated with symptoms of cerebral embolization
por: Biros, Erik, et al.
Publicado: (2017)

Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes
por: Hendrickx, Gretl, et al.
Publicado: (2020)

Arylsulfatase B Improves Locomotor Function after Mouse Spinal Cord Injury
por: Yoo, Myungsik, et al.
Publicado: (2013)

Brown Algae and Basalt Meal in Maintaining the Activity of Arylsulfatase of Soil Polluted with Cadmium
por: Zaborowska, Magdalena, et al.
Publicado: (2017)

Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study
por: í Dali, Christine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u35h50qnsdnfcrgh8ape2llau0